Hunter R. Murdock Net Worth

What's Hunter Murdock's mailing address?

Hunter's mailing address filed with the SEC is C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 22ND FLOOR, NEW YORK, NY, 10007.

Insiders trading at Axsome Therapeutics Inc

Over the last 9 years, insiders at Axsome Therapeutics Inc have traded over $3,013,485 worth of Axsome Therapeutics Inc stock and bought 82,512 units worth $1,366,003 . The most active insiders traders include Roger Jeffs, Susan Mahony oraz Mark Coleman. On average, Axsome Therapeutics Inc executives and independent directors trade stock every 114 days with the average trade being worth of $1,405,685. The most recent stock trade was executed by Mark E Saad on 11 September 2024, trading 11,016 units of AXSM stock currently worth $40,429.

What does Axsome Therapeutics Inc do?

axsome therapeutics is a biopharmaceutical company developing novel therapies for the treatment of cns disorders. axsome has a balanced portfolio of clinical development stage as well as research stage product candidates. the company is based in new york city.

Axsome Therapeutics Inc executives and stock owners

Axsome Therapeutics Inc executives and other stock owners filed with the SEC include:

• Herriot Tabuteau,
  Chairman of the Board, President, Chief Executive Officer, Founder
• David Marek,
  Chief Commercial Officer
• Nick Pizzie,
  Chief Financial Officer
• Dr. Herriot Tabuteau M.D.,
  Founder, Chairman, CEO & Pres
• Mark L. Jacobson,
  COO & Sec.
• Nick Pizzie CPA, M.B.A.,
  Chief Financial Officer
• Roger Jeffs,
  Lead Independent Director
• Mark Saad,
  Independent Director
• Mark Coleman,
  Independent Director
• Amanda Jones,
  Senior Vice President - Clinical Research
• Cedric O'Gorman,
  Senior Vice President - Clinical Development and Medical Affairs
• Mark Jacobson,
  Chief Operating Officer
• Joseph Debrah-Afful CPA, M.B.A.,
  Director of Fin.
• Kevin Laliberte Pharm.D.,
  Exec. VP of Product Strategy
• Lori Englebert M.B.A.,
  Sr. VP of Commercial & Bus. Devel.
• Dr. Amanda Jones Pharm.D.,
  Sr. VP of Clinical Devel.
• Constance Ames,
  Vice President, Finance
• Myrtle S Potter,
  Director
• Randall Kaye,
  Chief Medical Officer
• Hunter R. Murdock,
  General Counsel
• John Golubieski,
  Chief Financial Officer
• Susan Mahony,